developing therapeutic cancer vaccines
picture home vicinivax logo
Home company products technology news contact

Company
Profile
Business strategy
Management
Scientific advisory board
Investors
Partners

Investors

Hanzepoort BV

Kennis Conversie Fonds BV / RUG Houdstermaatschappij BV

Stichting G.J. Smid Fonds

VenGen Participaties BV
 
copyright 2024 © ViciniVax - disclaimer